Background Atrial fibrillation (AF) among patients with heart failure with reduced ejection
fraction (HF r EF) is associated with adverse clinical outcomes. Our primary aim was to …

Background Previous randomized controlled trials (RCT) s showed similar outcomes in
patients with atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF) …

Background Catheter ablation for atrial fibrillation (AF) is a proven alternative to
pharmacologic rhythm control in patients with heart failure with reduced ejection fraction …

Background The optimal treatment of atrial fibrillation (AF) in patients with heart failure with
reduced ejection fraction (HFrEF) remains unsettled. Objective The purpose of this study …

Importance Catheter ablation is associated with reduced heart failure (HF) hospitalization
and death in select patients with atrial fibrillation (AF) and heart failure with reduced ejection …

Purpose To evaluate whether catheter ablation is superior to conventional therapy for atrial
fibrillation (AF) in patients with heart failure with reduced ejection fraction (HFrEF). Methods …

Background: Catheter ablation (CA) continues to prove to be an intriguing therapeutic option
for the management of atrial fibrillation (AF) especially in patients with heart failure with …

Background The role of catheter ablation (CA) is increasingly recognized as a reasonable
therapeutic option in patients with atrial fibrillation (AF) and heart failure (HF). Hypothesis …

Background The benefit of catheter ablation in patients with atrial fibrillation (AF) for patients
with heart failure with preserved ejection fraction (HFpEF) remains uncertain. Objective We …

The prognostic benefit of catheter ablation (CA) for atrial fibrillation in the setting of heart
failure (HF) with reduced ejection fraction (EF) is unclear. A systematic search of medical …